Global Transcatheter Heart Valve Market by Technology (Balloon Expanded Transcatheter Valve, Self-Expanded Transcatheter Valve), by Application (Transcatheter Aortic Valve, Transcatheter Pulmonary Valve, Transcatheter Mitral Valve) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Market growth is driven by new products like third-generation heart valves

Global transcatheter market for heart valves was worth nearly USD 1.93 Billion in 2015. It is projected to grow to more than USD 8.62 Billion by 2024. These factors include an increase in the incidence of valvular diseases in people over 65, the introduction of third-generation transcatheter valves and favorable reimbursement policies in both the United States and the European Union (EU).

Healthcare providers around the globe are concerned about the rising mortality rate due to end-stage and chronic cardiovascular disease in the elderly population. According to the American Heart Association, almost 17.3 million people die each year from various cardiovascular diseases in 2015. Heart disease is the leading cause of death in America, accounting for around 375,000 deaths annually.

The healthcare system is facing a major problem due to the rising geriatric population. According to UN estimates, the U.S.'s geriatric population will reach more than 72 million in 2022. These valves will be more popular due to the growing population and increasing risk of developing end-stage heart disease. The PARTNER I clinical trials have strongly supported the benefits of transcatheter valve implantation and minimally invasive surgery.

North America Transcatheter Heart Valve Market, Application, 2013-2024 (USD Million).

Additionally, favorable reimbursement policies for patients, in the form government-sponsored Medicare, Medicaid plans and individual insurance policies are expected to increase the treatment rates of aortic and mitral regurgitation. These developments are expected positively to support the transcatheter market expansion over this forecast period. CMS issues one policy called Medicare National Coverage Determination. This policy allows coverage for these heart valves as part of Coverage with Evidence Development.

The transcatheter-aortic valve was the market.

Transcatheter Aortic Valve, pulmonary Valve, and Mitral Valve are the key segments. Transcatheter Aortic Valve was the most popular segment in 2015. This is due to rising healthcare costs, increased prevalence of chronic heart disease, and an increasing number of people suffering from severe aortic Stenosis. The key factors expected to increase usage rates are technological advances such as the tricuspid valve intervention, harpoon implementation, and neochord system.

Numerous clinical trials that demonstrated the importance of transcatheter replacement therapy for patients suffering from aortic regurgitation or other valvular diseases and inoperable patients have facilitated the adoption of this technology throughout the U.S.A. and EU. The Edwards Sapien 3 clinical trial, PARTNER II, which involved over 1000 patients in 50 locations across Canada and the U.S., showed better outcomes for various primary endpoints, such as stroke, mortality, or the ability to treat moderate-to-severe regurgitation.

The highest expected CAGR for the segment of transcatheter withral valve is 23.0% during the forecast period. This segment's growth is largely due to the Oct 2013 U.S. FDA approval for the transcatheter mitral fix device. The usage rate is expected to rise due to increasing awareness about the benefits of minimally invasive heart surgery and increased demand for treatment options for mitral regurgitation.

The fastest-growing technology is the balloon expanded transcatheter valle

The market for self-expanded transcatheter valve was 65.6% in 2015. This technology is used in most of the transcatheter heart valves, both first- and second-generation. The balloon catheters market is expected to grow at a rate of almost 17% due to technological advances, increased awareness about the benefits of balloon expandable valve systems, as well as improvements in clinical outcomes.

Asia Pacific Market to Grow at the Fastest Rate during the Forecast Period

Nearly 49% of the market share in 2015 was held by North America. Its high market share is due to increased investment in R&D, and increasing awareness about advanced transcatheter cardiac valve therapy. North America accounts for the largest share. The U.S. FDA approval of these products is a crucial milestone in commercialization. Additional factors that drive growth in the region include a robust reimbursement system, incentives for product development and collaboration among various stakeholders.

Asia Pacific is forecast to grow at a maximum CAGR rate of 17.8% during the forecast period. Japan and China are just two of the major markets for medical devices. There are few factors expected to drive the transcatheter market growth. These include the growing demand for new heart valve therapy devices and the rapidly developing healthcare sector. In India, for example, favorable government policies and reimbursement policies like Aarogyasri and Jeevandayee Arogya Yajana provide coverage for transcatheter heart treatments.

Edwards Lifesciences Corporation is a dominant player in transcatheter valves market

Boston Scientific Corporation, Bracco Group, Braile Biomedica, Direct Flow Medical, Edwards Lifesciences, JenaValve, St. Jude Medical, Symetis, ValveXchange, Inc. are some of the major players in the transcatheter valve market. This market is oligopolistic and is dominated Edwards Lifesciences and Medtronic. These companies actively seek out potential start-ups, and collaborate with various research centers to develop new products. Edwards Lifesciences Corporation bought CardiAQ Valve Technologies, Inc. in order to expand its reach into the market for mitral valve replacement.

Transcatheter Heart Valve Market Report Scope

These are the most frequently asked questions about this report

b. Global transcatheter market for heart valves was valued at USD 3.68 Billion in 2019, and is forecast to grow to USD 4.34 Billion by 2020.

b. Global transcatheter market for heart valves is expected to grow at 16.0% compound annual growth rate from 2017 to 2024, reaching USD 8.61 billion in 2024.

b. With a market share of 82.9%, transcatheter-aortic valve applications dominated the transcatheter valve market in 2019. This can be attributed to rising healthcare costs, increasing prevalence of chronic heart disease, and an increase in people suffering from severe aortic valve stenosis.

b. Boston Scientific Corporation, Bracco Group, Braile Biomedica, Direct Flow Medical, Edwards Lifesciences, JenaValve, St. Jude Medical, Symetis, ValveXchange, Inc. are some of the key players in the transcatheter market for heart valves.

b. The market growth is driven by the increasing prevalence of valvular diseases and the introduction of third-generation transcatheter valves.

Up Market Research published a new report titled “Transcatheter Heart Valve Market research report which is segmented by Technology (Balloon Expanded Transcatheter Valve, Self-Expanded Transcatheter Valve), by Application (Transcatheter Aortic Valve, Transcatheter Pulmonary Valve, Transcatheter Mitral Valve), By Players/Companies Inc to expand into the mitral valve replacement market, Braile Biomedica, Medtronic, Symetis, JenaValve, St Jude Medical These companies are actively scouting for potential start-ups and are also collaborating with different research centers for new product development For instance, Edwards Lifesciences Corporation acquired CardiAQ Valve Technologies, Bracco Group, Boston Scientific Corporation, ValveXchange, St Jude Medical, Inc The market is oligopolistic in nature and is dominated by Edwards Lifesciences, Direct Flow Medical, Edwards Lifesciences”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Transcatheter Heart Valve Market Report Segments:

The market is segmented by Technology (Balloon Expanded Transcatheter Valve, Self-Expanded Transcatheter Valve), by Application (Transcatheter Aortic Valve, Transcatheter Pulmonary Valve, Transcatheter Mitral Valve).

Transcatheter Heart Valve Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Transcatheter Heart Valve Market

Overview of the regional outlook of the Transcatheter Heart Valve Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Transcatheter Heart Valve Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Transcatheter Heart Valve Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Balloon Expanded Transcatheter Valve

                2. Self-Expanded Transcatheter Valve

                1. Transcatheter Aortic Valve

                2. Transcatheter Pulmonary Valve

                3. Transcatheter Mitral Valve

8. Market scenario by region, sub-region, and country.
9. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
10. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
11. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Transcatheter Heart Valve Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Transcatheter Heart Valve Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.